Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What are you talking about?
You mean CSO Dr Thomas Ichim? The one that took the 7 send
Stock medistem stem cell company and got it sold for $1.25 to intrexon?
Google the management and advisors of CELZ and let the facts speak for themselves
Founder of $celz is famous stem cell Doctor https://en.m.wikipedia.org/wiki/Amit_Patel
It's great they completed enrollment in the clinical trial ....you saw the press release ?
What people don't realize is that Dr Amit Patel, the cofounder of $celz is a top stem cell doctor in the world
He published his clinical trial in Lancet http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30137-4/supplemental
Stem cells for disc degeneration issued patent held by $celz
http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-to-expand-into-10-billion-dollar-per-year-lower-back-pain-market-with-acquisition-of-issued-us-stem-cell-patent-300459902.html
Read his employment contract https://www.lawinsider.com/contracts/o3nQqq0GDGx7iXX2H3Ouh/bio-matrix-scientific-group/1079282/2015-01-22
he quit before the 18 months were over
plus does this look like a sick man to you?
He quit because he founded the damn company, wrote all the patents, and the couldn't handle working with a bunch of incompetent people
He was too pollute to throw the company under the bus so he said he was "sick"...he was sick of the bs
Remember he quit knowing his shares would not vest
Magen he started $celz with head of surgery of university of Miami Amit Patel
Does anyone know why Thomas Ichim of CELZ creative medical technology holdings inc is publishing with this Company?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505307/
$CELZ is doing erectile dysfunction clinical trial and plans to generate revenue within the year
Is this through USRM?
Is there development deal for Amniostem new stem cell?
Alex
Hey I'm
Sorry
Just when first person to inject stem cells
In human heart/ head of cardiac surgery at university of
Miami http://med.miami.edu/news/dr.-amit-patel-named-chief-of-cardiac-surgery
Teams up with Santosh Kesari, top
Neurologist http://www.pacificneuroscienceinstitute.org/people/kesari/
Led by a guy who sold his last penny stock company to intrexon, thomas ichim
And they all
Have a company that is suppose to be revenue generating with st
Cells
I think it's something exciting
What don't you like about the company?
Best wishes
Alex
Say that to the poor Glioma and brain metastasis patients that are mentally deficient after whole brain irradiation you idiot
I agree ..just look at the patents they have....they control the future of genetic engineering
Thomas Ichim founded both Regen and CELZ, when he lost influence on the decision making process of regen he simply quit....
CELZ has an issued patent on using stem cells for reducing lower back pain through a completely new mechanism....stimulating new blood vessels around the spine to allow for endogenous repair processes to take over.
Here is the press release http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-to-expand-into-10-billion-dollar-per-year-lower-back-pain-market-with-acquisition-of-issued-us-stem-cell-patent-300459902.html
Internationally Known Cancer Expert is Behind TSOI Cancer Technology
It appears Dr Santosh Kesari, one of the most successful immunotherapists in the world is behind TSOI cancer work. Did you notice be is inventor on the issued
Patent ?
Here is his bio http://www.pacificneuroscienceinstitute.org/people/kesari/
This is the only sub penny stock that has this caliber of science
Definitely Long here
Excellent collaboration between CELZ and Dr Santosh Kesari from John Wayne Cancer Institute!!
https://finance.yahoo.com/news/creative-medical-technology-holdings-demonstrates-193000105.html?.tsrc=applewf
Wow the clinical trial that CELZ is doing at UCLA now for erectile dysfunction was demonstrated in one patient on 2013 in peer reviewed paper https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718667/
Having Amit Patel the stem cell mastermind, combined with Santosh Kesari and Alex Gershman makes this an unstoppable team in my opinion
No wonder Dr Thomas Ichim left intrexon $xon to work for
Timothy Warbington at creative medical technology
Very cool work in my opinion...did you read this paper? Aethlon was doing this work 10 years ago, now companies like Codiak are raising huge money around Exosomes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504474/
One of the very interesting companies in the space
They have very promising cancer treatment removing exosomes from blood of cancer patients
Dr Thomas Ichim is on to next venture, CELZ
https://finance.yahoo.com/news/creative-medical-technology-holdings-appoints-110000078.html?.tsrc=applewf
Creative Medical Technology Holdings Appoints Internationally Renowned Stem Cell Pioneer as Chief Scientific Officer
PR Newswire PR NewswireMarch 8, 2017
SAN DIEGO and PHOENIX, March 8, 2017 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (CELZ) announced today the appointment of Dr. Thomas Ichim to the position of Chief Scientific Officer. Dr. Ichim will lead development of the Company's clinical stage CaverStemTM personalized stem cell therapy for erectile dysfunction, as well as advance preclinical and eventually clinical studies on the Company's universal donor AmnioStemTM stem cell therapy for post-stroke recovery.
"It is my honor to welcome Dr. Ichim to the position of Chief Scientific Officer," said Timothy Warbington, President and CEO of CELZ. "I have known Dr. Ichim for more than 10 years and have witnessed him grow his previous company, Medistem Inc., from concept to FDA Investigational New Drug (IND) clearance, to eventual acquisition by the NYSE traded company Intrexon. I am confident that Dr. Ichim will put CELZ on the same trajectory of success."
SAN DIEGO and PHOENIX, March 8, 2017 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (CELZ) announced today the appointment of Dr. Thomas Ichim to the position of Chief Scientific Officer. Dr. Ichim will lead development of the Company's clinical stage CaverStemTM personalized stem cell therapy for erectile dysfunction, as well as advance preclinical and eventually clinical studies on the Company's universal donor AmnioStemTM stem cell therapy for post-stroke recovery.
"It is my honor to welcome Dr. Ichim to the position of Chief Scientific Officer," said Timothy Warbington, President and CEO of CELZ. "I have known Dr. Ichim for more than 10 years and have witnessed him grow his previous company, Medistem Inc., from concept to FDA Investigational New Drug (IND) clearance, to eventual acquisition by the NYSE traded company Intrexon. I am confident that Dr. Ichim will put CELZ on the same trajectory of success."
"Having published 20 peer-reviewed papers with Dr. Ichim over the last nine years, I greatly respect his unique ability to rapidly accelerate progress from concept, to patent, product. I look forward to continuing our collaborations in his new position," said Dr. Amit Patel, Cofounder and Board Member of CELZ, and Head of Cardiac Surgery at University of Miami.
"Dr. Ichim represents a true visionary in the area of cellular therapy, being one of the few people that effectively combines deep knowledge of basic science, regulatory affairs, and clinical translation. I plan to leverage our existing strengths at the Pacific Neurosciences Institute and at St John Providence to accelerate neurological uses of the Company's AmnioStemTM stem cell, particularly in the indication of post-stroke recovery," said Dr. Santosh Kesari, MD, PhD, FANA, FAAN, Scientific Advisory Board Member of CELZ. Dr. Kesari is Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, as well as Director of Neuro-oncology, Providence Saint John's Health Center and leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.